Comparison of Clinical and Demographic Features of Juvenile Spondyloarthropathies between Israeli and US Children

Nassem Ghantous 1 Merav Heshin-Bekenstein 2 Yaniv Lakovsky 1,3 Amir Moshe Hendel 1 Yonatan Butbul Aviel 4 Irit Tirosh 1,5 Liora Harel 1,3 Gil Amarilyo 1,3
1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Division of Pediatric Rheumatology, University of California San Francisco, Benioff Children's Hospital, 550 16th Street, 5th Floor, San Francisco, USA
3Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva 4920235, Israel
4Department of Pediatrics, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel
5Rheumatology Clinic, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel

Background: Clinical observations among Israeli pediatric rheumatologists reveal that some of the clinical and demographic features of Israeli children diagnosed with Juvenile Spondyloarthritis (JSpA) are different compared to the characteristics described in US studies.

Methods: We performed a retrospective, cross-sectional, multicenter cohort study of JSpA patients among 3 large Israeli pediatric rheumatology centers (Schneider, Tel-Hashomer, Rambam) and compared demographic and clinical features to an American cohort (University of California San Francisco) including subjects diagnosed with JSpA.

Results: Overall 87 patients (39 Israeli and 48 American patients) met the inclusion criteria. Axial symptoms and physical examination findings of sacroiliac joint tenderness upon presentation were found to be more prevalent among Israeli patients (p<0.05), whereas peripheral signs and symptoms, including arthritis and enthesitis were found to be more prevalent among American patients. 96.7% of Israeli patients vs. 29.7% of American patients demonstrated positive findings of sacroiliitis on MRI upon presentation (p<0.001). The prevalence of HLA-B27 positivity was 32% and 66.7% in the Israeli and the American cohorts, respectively (p=0.007).

Conclusion: The majority of Israeli children diagnosed with JSpA demonstrate different clinical features compared to other patient populations, emphasizing the axial involvement upon presentation and low HLA-B27 positivity prevalence. Further studies are needed to explore the genetic and environmental factors that are associated with these findings.









Powered by Eventact EMS